Identificação
Identificação pessoal
- Nome completo
- Clare Hoskins
Nomes de citação
- Hoskins, Clare
Identificadores de autor
- Ciência ID
- A312-40D0-337E
- ORCID iD
- 0000-0002-7200-0566
Telefones
- Telefone
-
- (+44) 141 Ext.: 5482796 (Profissional)
Moradas
- Technology and Innovation Centre, 99 George Street, G1 1RD, Glasgow, Glasgow, Reino Unido (Profissional)
Websites
- https://www.strath.ac.uk/staff/hoskinsclaredr/ (Profissional)
Domínios de atuação
- Ciências da Engenharia e Tecnologias - Nanotecnologia
- Ciências Exatas - Química - Química de Colóides
Idiomas
Idioma | Conversação | Leitura | Escrita | Compreensão | Peer-review |
---|---|---|---|---|---|
Inglês (Idioma materno) |
Formação
Grau | Classificação | |
---|---|---|
2012/09/01 - 2013/06/30
Concluído
|
PGCert in Teaching and Learning for Higher Education (Postgraduate Certificate)
Keele University, Reino Unido
|
Pass |
2006/10/01 - 2010/03/15
Concluído
|
PhD in Pharmaceutucs (Doctor of Philosophy)
Robert Gordon University, Reino Unido
"The use of Novel Poly(allylamine) Based Amphiphilic Polymers for Drug Delivery
" (TESE/DISSERTAÇÃO)
|
Paa |
2006/10/01 - 2007/06/30
Concluído
|
PG Cert In Research Methods (Postgraduate Certificate)
Robert Gordon University, Reino Unido
|
Pass |
2002/09/01 - 2006/06/30
Concluído
|
Applied Chemistry (Bachelor)
Robert Gordon University, Reino Unido
|
2:1 |
Percurso profissional
Ciência
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2009/12/01 - 2011/10/31 | Pós-doutorado (Investigação) | University of Dundee, Reino Unido |
Docência no Ensino Superior
Categoria Profissional Instituição de acolhimento |
Empregador | |
---|---|---|
2019/11/01 - Atual | Professor Associado (Docente Universitário) | University of Strathclyde, Reino Unido |
2016/04/01 - 2019/10/31 | Professor Associado (Docente Universitário) | Keele University, Reino Unido |
2011/11/01 - 2016/03/31 | Professor Auxiliar (Docente Universitário) | Keele University, Reino Unido |
Projetos
Bolsa
Designação | Financiadores | |
---|---|---|
2020/02/01 - Atual | Magnetic Nanotechnology to Treat Venous Thromboembolism
218671/Z/19/Z
Outra
|
UK Research and Innovation
Em curso
|
2022/03/01 - 2024/02/28 | EPSRC-IRC Hard to Treat Cancers
n/a
Project Partner
|
Engineering and Physical Sciences Research Council
Em curso
|
2022/01/01 - 2024/01/01 | Multiscale Metrology Suite for Next-Generation Health Nanotechnologies
n/a
CoI
|
Engineering and Physical Sciences Research Council
Em curso
|
2020/09/01 - 2023/06/30 | Novel nanomedicine for pancreatic cancer
n/a
Investigador responsável
|
Carnegie University Trust
Em curso
|
2020/09/01 - 2022/06/30 | Electrochemical sensing of nanomedicine fate in pancreatic cancer
n/a
Investigador responsável
|
Tenovus Cancer Care
Em curso
|
2021/05/01 - 2022/04/30 | PaNano-MRI: Use of targeted nanoparticles for early detection in pancreatic cancer
n/a
Investigador responsável
|
Cancer Research UK
Em curso
|
2018/05/01 - 2022/04/30 | Chemical study of insect-plant interactions: a contribution to biorational control of crop pests
info:eu-repo/grantAgreement/RCUK/BBSRC/BB2%FR0227552%F1/GB
|
UK Research and Innovation
Em curso
|
2021/01/11 - 2022/02/28 | Validation of use of femtosecond lasers in the nanotechnology market
n/a
Investigador responsável
|
Engineering and Physical Sciences Research Council
Concluído
|
2020/06/01 - 2021/06/30 | Quilts for Cancer
n/a
Investigador responsável
|
Royal Society of Chemistry
Em curso
|
2019/07/01 - 2020/06/30 | Antimicrobial nanoparticle platforms enhancing capacitabine efficacy in pancreatic cancer
JM/JR
Investigador responsável
University of Strathclyde, Reino Unido
|
North Staffordshire Medical Institute
Em curso
|
2015/06/01 - 2017/12/01 | Nanoparticle-induced Hyperthermia as a Novel Therapy for Cutaneous Leishmaniasis’
Outra
Keele University, Reino Unido
|
Wellcome Trust
Concluído
|
Produções
Publicações
Artigo em revista |
|
Propriedade Intelectual
Patente |
|
Atividades
Orientação
Título / Tema Papel desempenhado |
Curso (Tipo) Instituição / Organização |
|
---|---|---|
2022/10/01 - Atual | Oxygen sensitive upconversion nanoparticles
Coorientador
|
University of Strathclyde, Reino Unido
|
2022/05/01 - Atual | Thermo-responsive analogues for nanoparticle precision delivery in pancreatic cancer therapy
Orientador
|
University of Strathclyde, Reino Unido
|
2022/04/01 - Atual | Next generation nano-carriers for pancreatic cancer therapy
Orientador
|
University of Strathclyde, Reino Unido
|
2022/04/01 - Atual | A nano formulation strategy to enhance the therapeutic potential of exogenous
host defence peptides for inflammatory bowel disease and gastrointestinal infections
Coorientador
|
Edinburgh Napier University, Reino Unido
|
2021/06/01 - Atual | Evaluation of nanotoxicity of nano therapeutics for pancreatic cancer
Orientador
|
University of Strathclyde, Reino Unido
|
2021/01/01 - Atual | Silver hybrid push-pull particles for pancreatic cancer therapy
Orientador
|
University of Strathclyde, Reino Unido
|
2019/11/01 - Atual | Nanoparticle impregnated wafers for wound regeneration
Orientador
|
University of Strathclyde, Reino Unido
|
2019/06/01 - 2021/06/01 | Use of nanoparticles to improve the therapeutic
index of navitoclax
Coorientador
|
Keele University, Reino Unido
|
2019/06/01 - 2021/06/01 | Resorcinarene nanoparticles for drug solubilisation in pancreatic cancer
Coorientador
|
Keele University, Reino Unido
|
2018/05 - 2021/05/01 | Hydroxypropylmethacrylamide based thermoresponsive magnetomicelles for controllable drug delivery in pancreatic cancer.
Orientador
|
Keele University, Reino Unido
|
2018/06/01 - 2020/06/01 | Development of a novel doxorubicin delivery system for pancreatic cancer.
Orientador
|
Keele University, Reino Unido
|
2018/06/01 - 2020/06/01 | Resorcinarene-drug analogues for drug delivery
Coorientador
|
Keele University, Reino Unido
|
2017/06/01 - 2020/06/01 | Use of hybrid iron oxide-silver nanoparticles for thermo-responsive drug delivery in pancreatic cancer
Orientador
|
Keele University, Reino Unido
|
2018/06/01 - 2019/06/01 | Silver hybrid nanoparticles for pancreatic cancer
Orientador
|
Keele University, Reino Unido
|
2015/06/01 - 2018/06/01 | The co-administration of anticancer and pro-apoptotic agents as a novel approach in liver cancer therapy.
Orientador
|
Keele University, Reino Unido
|
2015/06/01 - 2018/06/01 | Synthesis of drug analogues for pancreatic cancer therapy
Coorientador
|
Keele University, Reino Unido
|
2013/06/01 - 2017/06/01 | Diels Alder-mediated release of gemcitabine from nanoparticles: developing improved methods for pancreatic cancer drug delivery
Orientador
|
Keele University, Reino Unido
|
2012/06/01 - 2016/06/01 | Preparation and evaluation of hybrid gold-iron oxide nanoparticles as a multifunctional platform for diagnosis and therapy
of pancreatic cancer
Orientador
|
Keele University, Reino Unido
|
Júri de grau académico
Tema Tipo de participação |
Nome do candidato (Tipo de grau) Instituição / Organização |
|
---|---|---|
2021/09/01 | Pharmaceutics
Arguente principal
|
¿ Jamila Al Mahrooqi (Doutoramento)
University of Reading, Reino Unido
|
2021/05/21 | Medicinal chemistry
Arguente principal
|
Mattheu Bruist (Mestrado)
Robert Gordon University, Reino Unido
|
2020/08/06 | Polymer chemistry
Arguente principal
|
¿ Abdolelah Jaradat (Doutoramento)
University of Nottingham, Reino Unido
|
2020/07/05 | Polymer chemistry
Arguente principal
|
¿ Charles Pearce (Doutoramento)
Queen Mary University of London, Reino Unido
|
2020/06/01 | Polymer chemistry
Arguente principal
|
¿ Sarah Blackmore (Doutoramento)
University of Liverpool, Reino Unido
|
2020/05/04 | Pharmaceutics
Arguente principal
|
¿ Saeed Akkad (Doutoramento)
University of Kent, Reino Unido
|
2020/04/08 | Metal organic frameworks
Arguente principal
|
¿ Panagiota Markopoulou (Doutoramento)
University of Glasgow, Reino Unido
|
2020/02/19 | Regenerative medicine
Arguente principal
|
¿ William Woods (Mestrado)
Keele University, Reino Unido
|
2019/10/03 | Cancer nanomedicine
Arguente principal
|
¿ Rachael Cameron (Doutoramento)
University of Strathclyde, Reino Unido
|
2019/03/02 | Medicinal chemistry
Arguente principal
|
¿ Nicholas Omonga (Doutoramento)
University of Salford, Reino Unido
|
2018/09/06 | Pharmaceutics
Arguente principal
|
¿ Ovara Abdullah (Doutoramento)
Islamic University of Bahalawapur, Paquistão
|
2018/09/02 | Molecular biology
Arguente
|
¿ Ali Wasif (Doutoramento)
Keele University, Reino Unido
|
2018/05/02 | Cancer nanomedicine
Arguente principal
|
¿ Shannon O’Neill (Doutoramento) |
2018/03/23 | Pharmaceutics
Arguente principal
|
Peter Stone (Doutoramento)
Aston University, Reino Unido
|
2018/03/17 | Cancer drug discovery
Arguente
|
¿ Mohammed Abo Donia (Doutoramento)
Keele University, Reino Unido
|
2018/02/12 | Cancer molecular biology
Arguente
|
¿ Chloe Gawlick (Mestrado)
Keele University, Reino Unido
|
2018 | Malaria drug discovery
Arguente
|
¿ Hamza Hameed (Doutoramento)
Keele University, Reino Unido
|
2018 | Polymer chemistry
Arguente principal
|
¿ Muqdam Ali (Doutoramento)
University of Nottingham, Reino Unido
|
2018 | Pharmaceutics
Arguente principal
|
¿ Noorjahan Aibani (Doutoramento)
Ulster University, Reino Unido
|
2017/08/30 | Pharmaceutics
Arguente principal
|
¿ Muhammad Rouk Akram (Doutoramento)
Islamic University of Bahalawapur, Paquistão
|
2017/07/09 | Pharmaceutics
Arguente principal
|
¿ Mandeep Marwah (Doutoramento)
Aston University, Reino Unido
|
2016/03/13 | Pharmaceutical manufacture
Arguente principal
|
¿ Eman Dahmash (Doutoramento)
Aston University, Reino Unido
|
2016/02/11 | Molecular biology
Arguente
|
¿ Michael Rotherham (Doutoramento)
Keele University, Reino Unido
|
2015/10/14 | Regenerative medicine
Arguente
|
¿ Rupert Wright (Doutoramento)
Keele University, Reino Unido
|
Arbitragem científica em conferência
Nome da conferência | Local da conferência | |
---|---|---|
2020/09/01 - Atual | CONTROLLED RELEASE SOCIETY ANNUAL MEETING 2021 | |
2021/07/01 - 2022/07/15 | CONTROLLED RELEASE SOCIETY ANNUAL MEETING 2022 - Conference Chair |
Membro de associação
Nome da associação | Tipo de participação | |
---|---|---|
2006/01/01 - Atual | Royal Society of Chemistry: Fellow |
Membro de comissão
Descrição da atividade Tipo de participação |
Instituição / Organização | |
---|---|---|
2019/06/01 - Atual | UK and Ireland Controlled Release Society
Membro
|
|
2016/01/01 - Atual | Royal Society of Chemistry: Chemical Nanosciences and Nanotechnology Interest Group: Secretary
Outro
|
Royal Society of Chemistry, Reino Unido |
2021/07/01 - 2024/06/30 | RSC Chemical Nanosciences and Nanotechnology Interest Group Chair
Presidente / Vice-presidente
|
Distinções
Prémio
2021 | Strathclyde Women in Leadership Network Award |
2019 | Emerging Scientist
Academy of Pharmaceutical Sciences, Reino Unido
|
2019 | Researcher Award
North Staffordshire Medical Institute, Reino Unido
|